These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 36336887

  • 1. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
    Cui S.
    J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
    [Abstract] [Full Text] [Related]

  • 2. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung Cancer].
    Zhang Y, Wang Y, Liu M.
    Zhongguo Fei Ai Za Zhi; 2024 Jan 02; 26(12):919-933. PubMed ID: 38163978
    [Abstract] [Full Text] [Related]

  • 3. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A).
    Zhou Y, Li J, Yang X, Song Y, Li H.
    Bioengineered; 2021 Dec 02; 12(2):12003-12022. PubMed ID: 34787052
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
    Wang J, Ding W, Xu Y, Tao E, Mo M, Xu W, Cai X, Chen X, Yuan J, Wu X.
    Aging (Albany NY); 2020 Mar 12; 12(5):4558-4572. PubMed ID: 32163372
    [Abstract] [Full Text] [Related]

  • 5. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X, Ren H, Zhang Y, Wang B, Ma H.
    Environ Toxicol; 2022 Dec 12; 37(12):3013-3027. PubMed ID: 36125241
    [Abstract] [Full Text] [Related]

  • 6. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z, Jin H, Duan X, Liu H, Zhao X, Fan S, Wang Y, Yao T.
    Environ Toxicol; 2021 Dec 12; 36(12):2562-2577. PubMed ID: 34520102
    [Abstract] [Full Text] [Related]

  • 7. METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling.
    Mao Y, Li W, Weng Y, Hua B, Gu X, Lu C, Xu B, Xu H, Wang Z.
    Cell Transplant; 2022 Dec 12; 31():9636897221122997. PubMed ID: 36073002
    [Abstract] [Full Text] [Related]

  • 8. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H, Zhou Y, Cheng H, Tian J, Yang S.
    Exp Mol Pathol; 2020 Aug 12; 115():104481. PubMed ID: 32497621
    [Abstract] [Full Text] [Related]

  • 9. M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling.
    Chen JQ, Tao YP, Hong YG, Li HF, Huang ZP, Xu XF, Zheng H, Hu LK.
    Cell Cycle; 2021 Dec 12; 20(23):2507-2518. PubMed ID: 34658294
    [Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L, Zhou Z, Gan Y, Li P, Xu Y, Zhang Z, Luo F, Xu J, Zhou Q, Dai F.
    J Cell Biochem; 2019 Jun 12; 120(6):9656-9666. PubMed ID: 30548308
    [Abstract] [Full Text] [Related]

  • 11. M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer.
    Cai Y, Zheng H, Xu D, Xie J, Wang W, Liu Z, Zheng Z.
    Pharmacology; 2024 Jun 12; 109(5):282-292. PubMed ID: 38744264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer.
    Zhang M, Wang J, Guo Y, Yue H, Zhang L.
    J Ovarian Res; 2023 Dec 19; 16(1):240. PubMed ID: 38115063
    [Abstract] [Full Text] [Related]

  • 16. Methyltransferase Like-3-Mediated N6-Methyladenosine Modification of Long Noncoding RNA Hepatocyte Nuclear Factor 1a Antisense RNA 1/Hepatocyte Nuclear Factor 4a Antisense RNA 1 Regulates Cytochrome P450 Enzyme Expression.
    Yu Y, Wang J, Xiong Z, Du A, Wang X, Wang Y, Han S, Wang P, Zhang L.
    Drug Metab Dispos; 2024 Sep 16; 52(10):1104-1114. PubMed ID: 39168523
    [Abstract] [Full Text] [Related]

  • 17. METTL3-mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway.
    Jia J, Yu L.
    Environ Toxicol; 2024 May 16; 39(5):2830-2841. PubMed ID: 38293837
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.